Initiation and Management of Norepinephrine Infusion in Shock

Fluid Resuscitation and Initial Dosing

• The Mayo Clinic recommends starting norepinephrine at 0.02–0.05 µg/kg/min (≈0.5 mg/h) via continuous IV infusion, preferably through central venous access, after giving at least 30 mL/kg crystalloid and targeting a MAP ≥ 65 mmHg. [@1]
• The World Journal of Emergency Surgery advises that hypovolemia must be corrected first with a minimum 30 mL/kg crystalloid bolus administered within the first 3 hours, either before or concurrently with vasopressor initiation. [@4]
• In patients with profound hypotension (SBP < 70 mmHg or DBP ≤ 40 mmHg), norepinephrine should be started emergently while fluid resuscitation continues, rather than waiting for complete volume repletion. [@6]
• For pregnant patients with sepsis, begin norepinephrine at 0.02 µg/kg/min and limit the initial fluid bolus to 1–2 L because of higher risk of pulmonary edema. [@1]

Vascular Access and Monitoring

• Central venous catheter placement is strongly preferred for norepinephrine infusion to minimize extravasation and tissue necrosis. [@1]
• Initiating norepinephrine through a large‑bore peripheral vein is considered safe until central access can be obtained, reducing treatment delays. [@4]
• Blood pressure and heart rate should be checked every 5–15 minutes during the initial titration phase. [@1]

Pediatric Dosing

• Critical Care Medicine recommends starting norepinephrine in children at 0.1 µg/kg/min, titrating within a range of 0.1–1.0 µg/kg/min, with maximum doses up to 5 µg/kg/min in refractory cases. [@7]

Target Hemodynamics and Titration

• The Mayo Clinic advises targeting a MAP of at least 65 mmHg in septic shock as the minimum threshold for adequate organ perfusion. [@1]
• MAP should be monitored together with lactate clearance, urine output ≥ 0.5 mL/kg/h, mental status, capillary refill ≤ 2 s, and skin perfusion to guide titration. [@7]

Escalation Strategies

• When norepinephrine reaches 0.1–0.25 µg/kg/min without adequate MAP, add vasopressin at 0.03 units/min as a second‑line agent; routine dosing should not exceed 0.03–0.04 units/min. [@1]
• If myocardial dysfunction persists despite MAP goals, add dobutamine at 2.5–20 µg/kg/min. [@4]
• For refractory shock despite high‑dose vasopressors, administer hydrocortisone 50 mg IV every 6 hours (or 200 mg/day continuous infusion). [@7]

Extravasation Management

• In case of norepinephrine extravasation, infiltrate phentolamine 5–10 mg diluted in 10–15 mL normal saline intradermally promptly to prevent tissue necrosis. [@6]

Monitoring Parameters

• Continuous arterial blood pressure monitoring via an arterial catheter is recommended. [@2]
• Hourly urine output should be targeted at ≥ 0.5 mL/kg/h. [@7]
• Lactate levels should be measured every 2–4 hours during early resuscitation. [@2]
• Mental status and peripheral perfusion (capillary refill, extremity temperature) should be assessed regularly. [@7]

Special Clinical Scenarios

• In hepatorenal syndrome, start norepinephrine at 0.5 mg/h and increase by 0.5 mg/h every 4 hours up to a maximum of 3 mg/h, aiming for a MAP increase ≥ 10 mmHg or urine output > 50 mL/h for at least 4 hours. [@2]
• For anaphylaxis refractory to epinephrine, initiate norepinephrine at 0.05–0.1 µg/kg/min after 10 minutes of epinephrine boluses and fluid resuscitation. [@2]
• Children with septic shock typically require 40–60 mL/kg of crystalloid in the first hour; norepinephrine should be started at 0.1 µg/kg/min for cold shock. [@7]
• Norepinephrine can be administered intraosseously with comparable onset to intravenous delivery; follow with a saline flush to promote central circulation. [@3]

Pitfalls to Avoid

• Do not delay norepinephrine while pursuing aggressive fluid resuscitation alone in severe hypotension (SBP < 70 mmHg or DBP ≤ 40 mmHg). [@2]
• Dopamine should not be used as first‑line therapy; it is associated with an 11% absolute increase in mortality and higher arrhythmia rates compared with norepinephrine. [@3]
• Low‑dose dopamine for renal protection provides no benefit and is discouraged. [@2]
• Phenylephrine as first‑line agent may raise blood pressure without improving tissue perfusion and should be avoided. [@2]
• Do not mix norepinephrine with sodium bicarbonate or other alkaline solutions, as this inactivates the drug. [@2]

Initial Norepinephrine Dosing and Management in Septic Shock

Pre‑Administration Fluid Resuscitation

• In adult patients with septic shock, administer a minimum crystalloid bolus of 30 mL per kg within the first 3 hours (≈2 L for a 70‑kg adult) before or concurrently with vasopressor initiation to correct hypovolemia【1】【2】.

Initiation and Dosing of Norepinephrine

• Begin norepinephrine at a weight‑based rate of 0.02 µg per kg per minute (≈1.4 µg /min or 0.5 mg /h for a 70‑kg adult) after the initial fluid bolus, delivered through central venous access【3】【4】.

Vascular Access and Hemodynamic Monitoring

• Central venous catheter is strongly preferred for norepinephrine infusion to minimize the risk of extravasation and tissue necrosis【1】【3】.
• If central access is unavailable, a large‑bore peripheral IV may be used safely until central access is obtained, reducing treatment delays【1】【2】.
• Place an arterial catheter for continuous blood‑pressure monitoring as soon as feasible【1】.
• During the initial titration phase, measure arterial blood pressure and heart rate every 5–15 minutes【3】.

Target Mean Arterial Pressure (MAP)

• For most septic‑shock patients, aim for a minimum MAP of 65 mmHg to ensure adequate organ perfusion【1】【2】【3】【5】.
• In patients with a history of chronic hypertension, a higher MAP target of 70–75 mmHg may reduce the incidence of renal replacement therapy【5】.
• In adults older than 65 years, a MAP target of 60 mmHg showed no increase in 90‑day mortality compared with a target of 65 mmHg, suggesting a lower target may be acceptable in this subgroup【1】.
• Routine targeting of MAP > 85 mmHg is not recommended; a multicenter trial demonstrated no mortality benefit and a higher rate of arrhythmias (36.6 % vs 34.0 % at 28 days)【5】.

Escalation Strategies for Refractory Hypotension

• When norepinephrine reaches 0.1–0.25 µg per kg per minute and MAP ≥ 65 mmHg cannot be achieved, add vasopressin 0.03 units per minute (do not exceed 0.03–0.04 U/min) as adjunct therapy【1】【3】.
• For refractory shock, consider hydrocortisone 50 mg IV every 6 hours (or continuous infusion of 200 mg/day) as an adjunctive agent【3】.

Extravasation Management

• If norepinephrine extravasates, inject phentolamine 5–10 mg diluted in 10–15 mL normal saline intradermally at the site immediately to prevent tissue necrosis【3】.

Initiation and Management of Norepinephrine for Persistent Hypotension

Fluid Resuscitation Prior to Vasopressor Initiation

• Administer a minimum crystalloid bolus of 30 mL/kg within the first 3 hours (≈ 2 L for a 70‑kg adult) before or concurrently with norepinephrine, to ensure adequate intravascular volume. 6
• In pregnant patients with sepsis, limit the initial fluid bolus to 1–2 L because of heightened risk of pulmonary edema, then start norepinephrine at 0.02 µg/kg/min. 6

Vascular Access and Delivery Considerations

• Central venous catheter placement is strongly preferred for norepinephrine infusion to minimize the risk of extravasation and tissue necrosis. 6
• When central access is unavailable, a large‑bore peripheral IV may be used safely to avoid treatment delays. 6

Initial Dosing and Titration

• Begin norepinephrine at 0.02 µg/kg/min (range 0.02–0.05 µg/kg/min), which corresponds to roughly 1.4 µg/min (≈ 0.5 mg/h) for a 70‑kg adult. 6

Hemodynamic Targets and Monitoring

• Target a minimum mean arterial pressure (MAP) of ≥ 65 mmHg in most patients with septic shock. 6
• In addition to MAP, routinely assess tissue perfusion markers:

Escalation Strategy for Refractory Hypotension

• If norepinephrine dose reaches 0.1–0.25 µg/kg/min without achieving MAP ≥ 65 mmHg, add vasopressin at 0.03 units/min (do not exceed 0.03–0.04 units/min). 6
• For shock that remains refractory after ≥ 4 h of high‑dose vasopressors, administer hydrocortisone 50 mg IV every 6 h (or 200 mg/day as a continuous infusion). 6